Kenneth Kesler, MD
Thoracic Surgery (Cardiothoracic Vascular Surgery) · Indianapolis, INNPI 1700991106
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 58 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Atricure, Inc. at 24.2% of the total. 2025 is the largest year on record at $1,103, 3.4 times the $326 reported in 2019. That places this record below the midpoint for thoracic surgery (cardiothoracic vascular surgery) clinicians in IN, where the typical reported total is $4,642.
Across 58 payments — averaging $48.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Atricure, Inc.$683
- Johnson & Johnson$442
- Merck$367
- Medtronic$365
- Artivion, Inc.$177
- Davol Inc.$162
- plus $631 from 9 others
Across 29 payments — averaging $10,173 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ethicon Endo-surgery Inc.$295K
What the payments were for
- Food & beverage$2,826100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Atricure, Inc. | 9 | $683 |
| Johnson & Johnson(2 entities) | 9 | $442 |
| Merck | 14 | $367 |
| Medtronic | 6 | $365 |
| Artivion, Inc. | 1 | $177 |
| Davol Inc. | 1 | $162 |
| Zimmer Biomet | 3 | $132 |
| Eisai Inc. | 4 | $113 |
| Sumitomo Pharma America, Inc. | 5 | $104 |
| Kls-martin L.p. | 1 | $100 |
| E.r. Squibb & Sons, L.L.C. | 1 | $84 |
| Corcept Therapeutics | 1 | $29 |
| Immunitybio, Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $23 |
| Kerecis Limited | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,826 in reported general payments places this provider in the 40th percentile of 127 thoracic surgery (cardiothoracic vascular surgery) providers in Indiana.
See all thoracic surgery (cardiothoracic vascular surgery) providers in Indiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other thoracic surgery (cardiothoracic vascular surgery) in Indianapolis
- Marc GerdischIndianapolis$1.4M
- Andrew BarksdaleIndianapolis$158K
- Manesh ParikshakIndianapolis$61K
- Ashish PulikalIndianapolis$36K
- Nakul ValsangkarIndianapolis$33K
- Karen RiegerIndianapolis$28K
- John FehrenbacherIndianapolis$26K
- John BrownIndianapolis$25K
- Vincent NardyIndianapolis$19K
- David HeimansohnIndianapolis$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.